Adeptus Biotechnologies Corp. (ADPT) PT Raised to $11 at BofA Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $25.62 +1.34%
Rating Summary:
13 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 12 | New: 90
Rating Summary:
13 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 12 | New: 90
Join SI Premium – FREE
BofA Securities analyst Derik de Bruin raised the price target on Adeptus Biotechnologies Corp. (NASDAQ: ADPT) to $11.00 (from $10.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Adeptus Biotechnologies Corp. (ADPT) PT Raised to $32 at TD Cowen
- Axis Capital Limited Upgrades Ashok Leyland Ltd. (AL:IN) to Buy (1)
- Salzgitter AG (SZG:GR) (SZGPY) PT Raised to EUR65 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Derik de BruinSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
